PM Modi unveils several development projects worth Rs 35,700 crore in Jharkhand

PM Modi Unveils Several Development Projects Worth Rs 35,700 Crore In Jharkhand

by Utkalika Mohanty

NEWS HIGHLIGHTS

Prime Minister Narendra Modi on Friday unveiled development projects worth more than Rs 35,700 crore, an initiative focused on the fertiliser, rail, power, and coal sectors in Jharkhand.

Dhanbad, Mar 1: Prime Minister Narendra Modi on Friday unveiled development projects worth more than Rs 35,700 crore, an initiative focused on the fertiliser, rail, power, and coal sectors in Jharkhand.

The Prime Minister dedicated to the nation the Hindustan Urvarak and Rasayan Ltd (HURL) Sindri Fertiliser Plant.

Developed at a cost of more than Rs 8,900 crore, the fertiliser plant is a step towards self-sufficiency in the urea sector.

It will add about 12.7 LMT per annum of indigenous urea production in the country, benefiting the farmers of the country. This is the third fertiliser plant to be revived in the country, after the revival of fertiliser plants at Gorakhpur and Ramagundam, which were also dedicated to the nation by the Prime Minister in December 2021 and November 2022, respectively.

The Prime Minister also inaugurated, dedicated and laid the foundation stone of several rail projects worth more than Rs 17,600 crore in Jharkhand.

The projects include the 3rd and 4th Line connecting Sone Nagar and Andal; the Tori-Shivpur first and second railway lines; and the Biratoli-Shivpur third railway line (part of the Tori-Shivpur Project); Mohanpur-Hansdiha new rail line; Dhanbad-Chandrapura rail line, among others. These projects will expand rail services in the state and lead to socio-economic development in the region.
The Prime Minister also flagged off three trains during the programme.

This includes the Deoghar-Dibrugarh train service, the MEMU train service between Tatanagar and Badampahar (Daily) and the long-haul freight train from Shivpur station.

Moreover, PM Modi dedicated to the nation important power projects in Jharkhand, including Unit 1 (660 MW) of the North Karanpura Super Thermal Power Project (STPP), Chatra."

Developed at more than Rs 7,500 crore, the project will lead to improved power supply in the region. It will also boost employment generation and contribute to socioeconomic development in the state.

Also, the Prime Minister dedicated to the nation projects related to the coal sector in Jharkhand.

Later, the Prime Minister will participate in a public programme where he will inaugurate, dedicate and lay the foundation stone of multiple development projects worth more than Rs 7,200 crore in Arambagh, Hooghly, West Bengal.

The Prime Minister is on a two-day visit to Jharkhand, West Bengal, and Bihar on March 1 and 2.

(ANI)

Read National News

BJP Approaches EC Over Sujata Karthikeyan's "Gross Misconduct for BJD's Electoral Gains" In Odisha

by Hemanta Pande

New Delhi/ Bhubaneswar, May 2: The central leaders of Bharatiya Janata Party (BJP) on Thursday approached the Election Commission here accusing Odisha’s Mission Shakti Department Secretary, Sujata Karthikeyan of “misusing” her position to mobilise women attached with self-help groups “for electoral gains" of the Biju Janata Dal (BJD).

A delegation led by Union Finance Minister Nirmala Sitharaman, Union Minister Rajeev Chandrashekhar, Rajya Sabha MP Sudhanshu Trivedi and senior party leader Om Pathak met the Election Commission and submitted a memorandum in this regard.

"Sujata Pandian, IAS, Commissioner cum Secretary, Mission Shakti, who is the wife of VK Pandian, also known as V Karthikeyan Pandian, is not only affiliated politically to the BJD, but also indulging in grave misconduct through misuse of authority, government machinery, and man power for influencing voters through 'SVEEP' for electoral gains of the BJD," the BJP leaders wrote in memorandum.

The BJP leaders alleged that VK Pandian, who also served as the Private Secretary to CM Patnaik for over a decade, wields considerable influence within the state’s administration.

“In November 2023, after taking voluntary retirement from IAS, Pandian joined the Biju Janata Dal (BJD) party. He was subsequently appointed as the chairman of the state’s flagship programme- 5T transformational initiatives with the rank of a Cabinet Minister...His proximity to the Chief Minister as well as the BJD cannot be overemphasized,” the memorandum reads.

"With a view to preserve the unbiased and unblemished reputation of ECI, it would be the fitness of things to relieve Sujata R. Karthikeyan, IAS, from the post of Commissioner-cum-Secretary, Department of Mission Shakti, Government of Odisha and not assigned any public dealing duty till the conclusion of the impending Parliamentary and Assembly Elections in the State of Odisha" it says.

SVEEP is the flagship programme of the Election Commission of India for voter education, spreading voter awareness and promoting voter literacy in the country.

Assembly and Lok Sabha elections will be held simultaneously in Odisha in four phases, starting from Phase one on May 13, Phase two on May 20, Phase three on May 25 and the final Phase on June 1.

The results will be announced on June 4.

Read More National News

Covaxin Has Excellent Safety Record, Says Bharat Biotech

by Hemanta Pande

Hyderabad, May 2: Bharat Biotech on Thursday said that its Covid-19 vaccine Covaxin has an excellent safety record without any vaccine-associated incidents of blood clots, thrombocytopenia, TTS, VITT, pericarditis, myocarditis, etc, as it was developed with a single-minded focus on safety first, followed by efficacy.

The Hyderabad-based company issued a statement amid questions being raised in some quarters over the safety of Covid vaccines after global pharmaceutical manufacturer AstraZeneca admitted that its Covid vaccine Covishield, developed by researchers from Oxford University, can cause a rare side effect of blood clotting and low platelet count after immunisation.

As many as 175 crore doses of Covishield, developed by AstraZeneca and manufactured by Pune-based Serum Institute, were reportedly administered in India.

Bharat Biotech mentioned that Covaxin was the only Covid-19 vaccine in the Indian government’s Covid-19 immunisation programme to have conducted efficacy trials in India.

"Covaxin was evaluated in more than 27,000 subjects as part of its licensure process. It was licensed under restricted use in clinical trial mode, where detailed safety reporting was carried out for several hundred thousand subjects," the vaccine manufacturer said.

The safety of Covaxin was also evaluated by the Ministry of Health.

"Ongoing safety monitoring (pharmacovigilance) was continued throughout the product life cycle of Covaxin. All the above studies and safety follow-up activities have demonstrated an excellent safety record for Covaxin without any vaccine-associated incidents of blood clots, Thrombocytopenia, TTS, VITT, pericarditis, myocarditis, etc.," it said.

"As seasoned innovators and product developers, the Bharat Biotech team was well aware that, while the efficacy of Covid-19 vaccines may be short-lived, the impact on patient safety could last a lifetime. Hence safety is the primary focus for all our vaccines," it added. (IANS)

PM Modi unveils several development projects worth Rs 35,700 crore in Jharkhand

Download Mobile App